2001 anthrax crisis in Washington, D.C.: clinic for persons exposed to contaminated mail.
An anthrax prophylaxis clinic is described. In October 2001, four workers from the U.S. Postal Service's Brentwood facility in Washington, D.C., were hospitalized with inhalational anthrax; many others may have been exposed to anthrax spores. U.S. Public Health Service (USPHS) teams were deployed to establish an anthrax prophylaxis clinic that would provide education and medication to workers and people who visited the mail facility. The temporary clinic was set up at D.C. General Hospital and was staffed primarily by health care professionals from USPHS. The protocol at the clinic involved three major phases. Phase 1 consisted of gathering information from the patient and distributing educational materials. Phase 2 involved presentations by a physician and a pharmacist concerning anthrax, followed by a question-and-answer session. In phase 3, a pharmacist selected the most appropriate prophylactic agent, dispensed the medication, counseled the patient, and referred patients with flu-like symptoms or skin lesions to a physician. Two floor plans were used to maximize the number of patients seen per hour without jeopardizing patient care. The clinic operated 14 hours a day for 14 days. The 136-member health care team included 52 pharmacists, and medication was dispensed to more than 18,000 patients. The clinic may serve as a model for pharmacists and other professionals in designing and implementing disaster plans. A multidisciplinary team established and operated a clinic to treat persons who may have been exposed to anthrax through contaminated mail.
Haffer
Andrew S T
AS
PHS-1 Disaster Medical Assistance Team, U.S. Public Health Service (USPHS), Division of Drug Marketing, Advertising, and Communications, Food and Drug Administration (FDA), Rockville, MD, USA. haffera@cder.fda.gov
Rogers
James R
JR
Montello
Michael J
MJ
Frank
Ellen C
EC
Ostroff
Craig
C
D000554:Ambulatory Care Facilities; D000881:Anthrax / Q000188:drug therapy / Q000628:therapy* / Q000635:transmission*; D004219:District of Columbia; D006801:Humans; D010343:Patient Admission; D010353:Patient Education as Topic; D023481:Terrorism